Advertisement
News
Advertisement

Mylan Launches Generic Percodan

Thu, 05/05/2011 - 5:02am

Mylan’s subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals. This product is the generic version of Endo Pharmaceuticals' Percodan Tablets, a treatment for moderate to severe pain.

Oxycodone and Aspirin Tablets had U.S. sales of approximately $6.5 million for the 12 months ending Dec. 31, 2010, according to IMS Health.

 

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading